U.S. market Closed. Opens in 2 hours 45 minutes

KPRX | Kiora Pharmaceuticals, Inc. Stock Overview

(Stock Exchange: NASDAQ)
Day's Range 3.27 - 3.49
52 Week Range 3.00 - 8.98
Beta N/A
Implied Volatility N/A
IV Rank N/A
Day's Volume 15,942
Average Volume 24,655
Shares Outstanding 3,000,790
Market Cap 10,262,702
Sector Healthcare
Industry Biotechnology
IPO Date 2015-02-13
Valuation
Profitability
Growth
Health
P/E Ratio 3.26
Forward P/E Ratio N/A
EPS 1.05
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 12
Country USA
Website KPRX
Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 1 clinical trial that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases. The company is also developing KIO-101, an eye drop that is in Phase 2 clinical trial for the treatment of ocular presentation of rheumatoid arthritis, as well as for treating non-infectious posterior uveitis; and KIO-201, an eye drop, which is in Phase 3 clinical trial for treating patients undergoing PRK surgery for corneal wound repair after refractive surgery. The company was formerly known as Eyegate Pharmaceuticals, Inc. and changed its name to Kiora Pharmaceuticals, Inc. in November 2021. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah.
*Chart delayed
Analyzing fundamentals for KPRX we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is poor, Growth is bad and Health is weak. For more detailed analysis please see KPRX Fundamentals page.

Watching at KPRX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on KPRX Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙